Skip to main content

Advertisement

Fig. 4 | Stem Cell Research & Therapy

Fig. 4

From: GMP-compatible and xeno-free cultivation of mesenchymal progenitors derived from human-induced pluripotent stem cells

Fig. 4

Expression of mesenchymal markers. Flow cytometry analysis showing the expression of common mesenchymal markers in induced pluripotent stem cell-derived mesodermal progenitors (line 1013A and BC1) cultured in different media at passages 7, 9, 11, 13, and 15. Data represent averages ± SD (n = 3, one-way ANOVA and repeated measures ANOVA with Bonferroni correction, p < .05). *Significant differences between FBS and Allegro™; #significant differences between FBS and HPL; $significant differences between Allegro™ and HPL; the numbers denote significant differences between passages in the same medium. Abbreviations: MP, mesodermal progenitors; FBS, fetal bovine serum; HPL, human platelet lysate; P, passage

Back to article page